Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DTYP21
|
|||
Drug Name |
CA102N
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Phase 1 | [1] | |
Company |
Holy Stone Healthcare
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT03616574) First-in-human Study of CA102N Monotherapy and of CA102N Combined With Trifluridine/Tipiracil (LONSURF) in Subjects With Advanced Solid Tumors. U.S. National Institutes of Health. | |||
REF 2 | National Cancer Institute Drug Dictionary (drug name CA102N). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.